
Frontier Bio is a biotechnology company creating lab-grown human tissues to improve medical research and patient care. What makes Frontier Bio unique is its focus on building living human tissues, starting with blood vessels, to replace animal testing and address organ shortages. By using patient-derived cells, Frontier Bio aims to create safer, more effective treatments and move medicine toward a future with on-demand human tissues.

Investment Details
Funding Round
Seed
Milestones
Funded in 2024
.avif)
About the Founder
Eric Bennett
Eric Bennett is the founder and CEO of Frontier Bio, a serial entrepreneur with expertise in biomedical engineering and bioprinting. His work focuses on developing engineered human tissues to replace animal testing and advance the future of medicine.
Real Investors. Real Outcomes.
Start Your Investing Journey with Portfolia
Our live overview sessions are the best way to experience how Portfolia is transforming venture capital and why the experience is unmatched.
- MEET OUR PARTNERS
- LEARN HOW OUR FUNDS WORK
- SEE THE COMPANIES WE'RE BACKING.


